The vivaCT 80 offers the largest field-of-view (80 mm) and the best resolution (5 µm) in its category and is hence the most versatile scanner for the in-vivo X-ray micro computed-tomography ...
vivaCT 40 is a fast and flexible in vivo microCT for preclinical studies. The low X-ray dose allows serial measurements of individuals. Whole-body scans or scans from selected regions of mice can ...
RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in ...
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
Micro-X selected by ARPA-H to develop world-first mobile CT for regional US healthcare under $16.m PARADIGM contract.
3d
Futurism on MSNMicroplastics Getting Stuck in Brain Vessels Like Clots, Scientists Find, Causing "Neurological Abnormalities" in MiceScientists tracked tiny pieces of microplastics as they moved through the brain blood vessels of mice. Some of them became ...
Super Micro faces increased competitive pressures, losing 300 bp of market share, with Nvidia increasingly shifting its partnership to Foxconn, impacting Super Micro's outlook. Financial concerns ...
Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...
New customers only. Deposit min. $5. Place first bet of min $5 and get $150 in bonus bets if your bet wins. FanDuel Sportsbook's welcome offer places it among the least restrictive betting bonuses ...
Get top local stories in Connecticut delivered to you every morning. Sign up for NBC Connecticut's News Headlines newsletter. His e-commerce experience fueled hopes that he could help modernize ...
Super Micro Computer stock is gaining ground ahead of a business update conference the company has scheduled for tomorrow. The conference could include preliminary Q2 results and information about ...
This broad approach, called in vivo cell therapy, has the potential to offer the best of both worlds, with scalability and lower cost, not to mention a better safety profile, while maintaining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results